期刊文献+

VEGF—C和HER一2在乳腺癌中表达的相关性 被引量:1

Relationship between VEGF - C and HER - 2 expressed in human breast cancer
下载PDF
导出
摘要 目的探讨血管内皮细胞生长因子-c(VEGF—C)和HER-2在乳腺癌转移中的作用及其二者的相关性,为针对性的治疗提供依据。方法采用免疫组化S—P法检测42例乳腺癌组织中VEGF—C和HER-2的表达。在光镜下进行阳性细胞的计数和染色强度分级。结果42例乳腺癌组织VEGF—C阳性率为71.4%(30/42),HER-2阳性率为38.1%(16/42),VEGF—C阳性率转移组(90.9%)高于未转移组(50.0%),P〈0.01;HER-2的阳性表达与淋巴结转移也密切相关(P〈0.05)。VEGF—C比HER-2的阳性率高,16例HER-2表达阳性的病例中有15例VEGF—C的表达阳性(P〈0.05)。结论VEGF—C和HER-2的表达均与肿瘤细胞经淋巴管的转移密切相关,VEGF—C的表达有相对独立性,HER-2可以加强VEGF—C的表达。 Objective To study the relationship between vascular endothelia growth factor- C ( VEGF -C) and HER - 2 expressed in human breast cancer. Methods S - P immunobistochemical staining was used to detect the expression of VEGF - C and HER - 2 in 42 cases of primary breast cancer. Results Among 42 cases of breast cancer, the positivity rate of VEGF- C was 71.4% (30/42). The positivity expression of VEGF -C in primary breast cancer with lymph node metastasis 90.9% was obviously higher than that in no lymph node metastasis cases 50.0% ( X^2= 6.70 〉 6.63, P 〈 0. 01 ) ; and HER - 2 was overexpressed in 38.1% ( 16/42 ) of breast cancer; HER - 2 expression level was correlated with lymph node metastasis ( X^2 = 4.95 〉 3.84, P 〈 0. 05). The expression of VEGF -C in HER -2 positive breast cancer was significantly higher than that in HER- 2 negative breast cancer( P 〈0.05). Conclusion The expression of VEGF- C and HER-2 was related to local lymph node metastasis in primary breast cancer; VEGF -C can express in primary breast cancer independent. But the expression of HER -2 of tumor ceils can contribute to secretion of VEGF - C.
出处 《中原医刊》 2007年第6期6-8,共3页 Central Plains Medical Journal
关键词 乳腺肿瘤 血管内皮细胞生长因子C HRE-2 肿瘤转移 Breast cancer Vascular endothelia growth factor- C HER -2 Tumor metastasis
  • 相关文献

参考文献11

  • 1Stacker SA, Caesar C, Baldwin M, et al. VEGF - D promotes the metastatic spread of tumor cells via the lymphatics. Nature Medicine, 2001,7:186-191.
  • 2Veiddola T, Jussila L, Makinen T,et al. Signalling via vascular endothelial growth factor receptor - 3 is sufficient for lymphangiogenesis in transgenic mice. European Molecular Biology Organization ,2001,20:1223 - 1231.
  • 3刘芳,张雅洁.VEGF-C及其受体Flt-4在乳腺癌细胞增殖及转移中的作用[J].癌症,2003,22(10):1053-1056. 被引量:27
  • 4李中海,王敬泽.血管内皮生长因子-C与肿瘤细胞转移[J].生命的化学,2003,23(4):300-302. 被引量:1
  • 5Wang JF, Ganju RK,Liu ZY, et al. Signal transduction in human hematopoietic cells by vascular endothelial growth factor related protein, a novel ligand for the FLT4 receptor. Blood, 1997, 90 (9) :3507 -3515.
  • 6杨栓平,江泽飞,宋三泰.HER-2蛋白过表达及信号转导通路[J].国外医学(肿瘤学分册),2003,30(2):83-85. 被引量:6
  • 7Gottffied E, Konecny Y, Meng G, et al. Association between HER - 2 and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patients. Clinical Cancer Research,2004,(10) :1706 - 1716.
  • 8Jiang BH, Agani F, Passaniti A. V - SRC induces expression of hypoxia- inducible factor 1 ( HIF - 1 ) and transcription of genes encoding vascular endothelial growth factor and enulase 1 : involvement of HIF - 1 intumor progression. Cancer Res, 1997,57 : 5328 - 5335.
  • 9Ravi R, Mookerjee B, Bhujwalla ZM, et al. Regulation of tumor angiogenesis by p53 - induced degradation of hypoxia - inducible factor 1.Genes Dev,2000,14:34 -44.
  • 10Tsai PW,Shiah SG, Lin MT, et al. Up - regulation of vascular endothelial growth factor C in breast cancer cells by heregulin - β1. J Boilchem,2003,278 (21) :5750 -5759.

二级参考文献28

  • 1Karpanen T et al. J Exp Med, 2001,194(6):37----42.
  • 2Gershenwald JE et al . Science, 2002,296:1811--1812.
  • 3Meyer M et al. EMBO J, 1999,18:363--374.
  • 4Mandriota SJ et al. EMBO J, 2001,20(4) :672----682.
  • 5lljin K et al. FASEB, 2001, 15:1028--1036.
  • 6Zachary I. Am J Physiol cell Physiol, 2001,280 : 1375--1386.
  • 7Veikkola T et al. EMBO J,2001, 20:1223--1231.
  • 8Karpanen T et al. Cancer Research, 2001, 61:1786--1790.
  • 9Padera TP et al. Science, 2002,296:1883--1886.
  • 10Niki T et al. Clinical Cancer Research, 2000, 6:2431--2439.

共引文献31

同被引文献30

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部